The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of circulating CD103+ T cells with major pathological response in a randomized phase 2 trial of neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small cell lung cancer.
 
Zachary Walsh
No Relationships to Disclose
 
Johannes C Melms
No Relationships to Disclose
 
Meri Rogava
No Relationships to Disclose
 
Lindsay Caprio
No Relationships to Disclose
 
Casey Ager
No Relationships to Disclose
 
Amit Dipak Amin
No Relationships to Disclose
 
Patricia Ho
No Relationships to Disclose
 
Murtaza Malbari
No Relationships to Disclose
 
Vivek Mittal
No Relationships to Disclose
 
Timothy McGraw
No Relationships to Disclose
 
Nasser K. Altorki
Stock and Other Ownership Interests - Angiocrine Bioscience; tomorrow; View Point Medical
Honoraria - AstraZeneca; Regeneron
Research Funding - AstraZeneca (Inst); Janssen Research & Development (Inst)
 
Benjamin Izar
Honoraria - AstraZeneca; Eisai; Janssen; Merck; Volastra Therapeutics
Consulting or Advisory Role - AstraZeneca; Janssen; Volastra Therapeutics